News outlets report on efforts to develop a safe and effective vaccine for Ebola.

Agence France-Presse: Experimental Ebola vaccines ready by 2015: WHO
“Thousands of doses of experimental Ebola vaccines could be ready for use in African countries badly hit by the deadly virus early next year, the World Health Organization said Friday…” (Larson, 9/26).

Associated Press: WHO: 1000s of Ebola vaccine doses in coming months
“Thousands of doses of experimental Ebola vaccines should be available in the coming months and could eventually be given to health care workers and other people at high risk of the deadly disease, the World Health Organization said Friday…” (DiLorenzo/Cheng, 9/26).

DoD News: Hagel: DoD to Begin Safety Testing for Ebola Vaccine Candidate
“The Defense Department has made critical contributions to the fight against the deadly Ebola outbreak in West Africa, and [Friday] Defense Secretary Chuck Hagel described additional ways the Pentagon is helping in the broader battle against infectious disease outbreaks of the future…” (Pellerin, 9/26).

Reuters: WHO sees small-scale use of experimental Ebola vaccines in January
“The World Health Organization (WHO) said on Friday it expected to begin small-scale use of two experimental Ebola vaccines in West Africa early next year and in the meantime, transfusions of survivors’ blood may offer the best hope of treatment…” (Nebehay, 9/26).

Reuters: European agency collects data on experimental Ebola treatments
“The European Medicines Agency said on Friday it had started collecting data from pharmaceutical companies trialing experimental medicines to treat Ebola in a bid to speed up the process to find an approved cure for the virus…” (Schaps, 9/26).

Reuters: Scientists grapple with ethics in rush to release Ebola vaccines
“Normally it takes years to prove a new vaccine is both safe and effective before it can be used in the field. But with hundreds of people dying a day in the worst ever outbreak of Ebola, there is no time to wait…” (Kelland, 9/28).

SciDev.Net: Q&A on fast-tracking Ebola vaccine human trials
“…SciDev.Net spoke to Adrian Hill, director of the Jenner Institute at the University of Oxford and lead researcher for the U.K.-based [Ebola vaccine] trials. He told us about the exceptionally fast review process that enabled scientists to start the trials within a few weeks rather than the usual six to 12 months, the international collaboration driving the fight against Ebola, and his hope that a vaccine could be available by the end of the year…” (Mathers, 9/26).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.